• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novaccess Global Inc (OP: XSNX )

    0.0083 UNCHANGED
    Streaming Delayed Price Updated: 3:16 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Novaccess Global Inc

    < Previous 1 2 Next >
    NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine Platform
    Via ACCESSWIRE
    NovAccess Global Advisory on Annual Meeting of Shareholders
    Via ACCESSWIRE
    NovAccess Global Announces New License to Advance its Immunotherapy Platform
    Via ACCESSWIRE
    NovAccess Global Announces $10.7 Million Financing
    Via ACCESSWIRE
    NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board
    Via ACCESSWIRE
    NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
    Via ACCESSWIRE
    NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements
    Via ACCESSWIRE
    Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award
    Via ACCESSWIRE
    NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day
    Via ACCESSWIRE
    NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division
    Via ACCESSWIRE
    NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies
    Via ACCESSWIRE
    NovAccess Global to Present at World Orphan Drug Congress
    Via ACCESSWIRE
    NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress
    Via ACCESSWIRE
    NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics Division
    Via ACCESSWIRE
    NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate
    Via ACCESSWIRE
    NovAccess Global Announces Virtual Annual Shareholders' Meeting
    Via ACCESSWIRE
    NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory Board
    Via ACCESSWIRE
    NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1
    Via ACCESSWIRE
    NovAccess Global Announces Fireside Chat with Board Member Perspectives
    Via ACCESSWIRE
    NovAccess Global Announces Fireside Chat Series for the Investment Community
    Via ACCESSWIRE
    NovAccess Global Announces Effectiveness of Form S-1 Registration Statement
    Via ACCESSWIRE
    NovAccess Global Announces Uplisting to OTCQB
    Via ACCESSWIRE
    CORRECTION: NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1
    Via ACCESSWIRE
    NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1
    Via ACCESSWIRE
    CORRECTION: NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1
    This corrects the release that ran earlier today, replacing the name of the executive quoted in the press release and other minor edits. 
    From NovAccess Global Inc.
    Via AccessWire
    Exposures Product Safety
    NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1
    Accelerating on the Path Toward Immunotherapy for Glioblastoma (Brain Cancer) 
    From NovAccess Global Inc.
    Via AccessWire
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    NovAccess Global CEO Dwain Irvin Featured on MoneyTV
    CLEVELAND, OH / ACCESSWIRE / June 14, 2022 / NovAccess Global Inc. (OTC PINK:XSNX) announced that its Chief Executive Officer Dr. Dwain Irvin was a featured guest on MoneyTV, an... 
    From NovAccess Global Inc.
    Via AccessWire
    Exposures Product Safety
    This Week on MoneyTV with Donald Baillargeon, 6/10
    HOLLYWOOD, CA / ACCESSWIRE / June 10, 2022 / Cancer treatment, metaverse, coping; this week on MoneyTV with Donald Baillargeon 
    From MoneyTV
    Via AccessWire
    NovAccess Global to Participate in LD Micro Invitational XII Conference
    CLEVELAND, OH / ACCESSWIRE / May 19, 2022 / NovAccess Global Inc. (OTC PINK:XSNX) announced that its Chief Executive Officer Dr. Dwain Irvin is scheduled to participate in the LD Micro Invitational XII... 
    From NovAccess Global Inc.
    Via AccessWire
    Topics Intellectual Property
    Exposures Intellectual Property
    NovAccess Global Stock Redemption and Expanded Board of Directors Reinforces Shareholder Value and Positions the Company to Accelerate Objectives
    LOS ANGELES, CA / ACCESSWIRE / March 17, 2022 / NovAccess Global Inc. (OTC PINK:XSNX) announced today the closing of a series of transactions which results in the reduction of potential common stock... 
    From NovAccess Global Inc.
    Via AccessWire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.